Bioequivalence of AmbrectTM Tablet to MucopectTM Tablet (Ambroxol hydrochloride 30 mg) |
Yoo, Jeong-Yeon
(Department of Drug Development Service, BioCore Co., Ltd.)
Joung, Sun-Koung (Department of Drug Development Service, BioCore Co., Ltd.) Choi, Mee-Hee (Department of Drug Development Service, BioCore Co., Ltd.) Han, Sang-Beom (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories,Department of Drug Development Service, BioCore Co., Ltd.) Lee, Kyung-Ryul (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories,Department of Drug Development Service, BioCore Co., Ltd.) Lee, Hee-Joo (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories,Department of Drug Development Service, BioCore Co., Ltd.) |
1 | 식품의약품안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002.11.22) |
2 | F. J. Flores-Murrieta, C. Hoyo-Vadillo, E. Hong and G. Castaneda-Hernandez, Assay of ambroxol in human plasma by high-performance liquid chromatography with amperometric detection. J. Chromatogr., 490, 464-469 (1989) DOI ScienceOn |
3 | Y. J. Lee, Y. G. Kim, M. G. Lee, S. J. Chung, M. H. Lee and C. K. Shim, Analysis of bioequivalence study using log-transformed model. Yakhakhoeji,44, 308-314 (2000) |
4 | 식품의약품안전청 고시 제 2002-61호, 의약품동등성시험관리규정 (2002. 11. 22) |
5 | Von H. Vergin, G. B. Bishop-Freudling, M. Miczka, V. Nitsche, K. Strobel and F. Matzkies, The pharmacokinetics and bioequivalence of various dosage forms of ambroxol. Arzneimittelforschung, 35, 1591-1595 (1985) |